Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
J Am Coll Cardiol. 2018 Jul 10;72(2):202-227. doi: 10.1016/j.jacc.2018.05.026.
The intersection of oncological and cardiovascular diseases is an increasingly recognized phenomenon. This recognition has led to the emergence of cardio-oncology as a true subspecialty. This field is not simply limited to primary cardiac tumors or complications of chemotherapeutic medications. Rather, it also encompasses metastatic cardiovascular complications and secondary cardiovascular effects of the underlying neoplasia. This review will broadly cover primary and metastatic cardiac neoplasms, as well as secondary cardiovascular effects of extracardiac neoplasia (e.g., amyloidosis, carcinoid valvulopathy, and chemotherapeutic cardiotoxicities).
肿瘤学和心血管疾病的交叉是一个日益被认识到的现象。这种认识导致了肿瘤心脏病学作为一个真正的亚专科的出现。这个领域不仅仅局限于原发性心脏肿瘤或化疗药物的并发症。相反，它还包括转移性心血管并发症和潜在肿瘤的继发性心血管效应。这篇综述将广泛涵盖原发性和转移性心脏肿瘤，以及心脏外肿瘤的继发性心血管效应（例如，淀粉样变性、类癌瓣膜病和化疗性心脏毒性）。
